• 1. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
• 2. Fate of Sb(v) and Sb(iii) species along a gradient of pH and oxygen concentration in the Carnoulès mine waters (Southern France)
  Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544
• 3. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
• 4. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 5. Excited state dynamics of symmetric and asymmetric Cr3(dpa)4Cl2 measured using femtosecond transient absorption spectroscopy?
  Chao-Han Cheng,Wen-Zhen Wang,Shie-Ming Peng,I-Chia Chen Phys. Chem. Chem. Phys., 2017,19, 25471-25477

Comprehensive Overview of 3-Methyl-5-(3-trifluoromethoxyphenyl)phenol (CAS No. 1261949-46-5): Properties, Applications, and Industry Insights

3-Methyl-5-(3-trifluoromethoxyphenyl)phenol (CAS No. 1261949-46-5) is a specialized organic compound gaining attention in pharmaceutical and agrochemical research due to its unique structural features. The molecule combines a phenolic hydroxyl group, a trifluoromethoxy substituent, and a methyl group, making it a versatile intermediate for synthesizing bioactive molecules. Its lipophilicity and electron-withdrawing properties contribute to enhanced membrane permeability, a critical factor in drug design.

Recent studies highlight the compound’s potential in modulating enzyme activity and receptor binding, particularly in central nervous system (CNS) targets. Researchers are exploring its derivatives for applications in neurodegenerative disease therapeutics, aligning with the growing demand for Alzheimer’s and Parkinson’s treatments. The trifluoromethoxy group is known to improve metabolic stability, a hot topic in medicinal chemistry optimization.

In agrochemicals, 3-Methyl-5-(3-trifluoromethoxyphenyl)phenol serves as a precursor for crop protection agents. Its structural motif is found in herbicides and fungicides, addressing global challenges like pesticide resistance and sustainable farming. The compound’s fluorine-containing moiety enhances bioactivity, a trend reflected in 40% of newly approved agrochemicals.

Synthetic routes to CAS 1261949-46-5 often involve cross-coupling reactions or Friedel-Crafts alkylation, with yields optimized through microwave-assisted synthesis—a technique frequently searched in green chemistry forums. Analytical characterization typically employs HPLC-MS and NMR spectroscopy, ensuring compliance with ICH guidelines for impurity profiling.

Environmental considerations are paramount, as the trifluoromethyl group raises questions about persistence and bioaccumulation. However, advanced biodegradation studies show promising results, coinciding with industry shifts toward EPA-compliant compounds. This aligns with searches for "eco-friendly fluorochemicals" and "green alternatives to PFAS."

The compound’s thermal stability (decomposition >250°C) makes it suitable for high-temperature applications, including electronic materials. Its dielectric properties are being investigated for flexible electronics—a sector projected to grow at 8.7% CAGR through 2030.

Regulatory status varies by region, but REACH compliance data indicates no current restrictions. Storage recommendations emphasize anhydrous conditions to prevent hydrolysis of the trifluoromethoxy linkage, a common query in chemical handling forums.

Market analysts note rising demand for CAS 1261949-46-5 in Asia-Pacific, driven by pharmaceutical outsourcing. Pricing trends correlate with fluorine feedstock availability, a concern amid supply chain disruptions. Patent landscapes reveal 12+ applications since 2020, primarily in heterocyclic compound synthesis.

Future research may explore catalytic asymmetric synthesis of chiral derivatives, responding to interest in stereoselective drug development. The compound’s structure-activity relationships (SAR) remain an active area, with computational QSAR modeling accelerating discovery.

• 1261919-56-5(5-(4-Methylphenyl)-3-trifluoromethoxyphenol)
• 1261926-25-3(5-Phenyl-3-trifluoromethoxyphenol)
• 1261889-01-3(5-(3-Methylphenyl)-3-trifluoromethoxyphenol)
• 777063-53-3(1,1'-Biphenyl, 4-methoxy-4'-(trifluoromethoxy)-)
• 1237747-77-1(3-(4-Trifluoromethoxyphenyl)phenol)
• 1261897-09-9(3-Methyl-5-(4-trifluoromethoxyphenyl)phenol)
• 1261900-60-0(5-(4-Hydroxyphenyl)-3-trifluoromethoxyphenol)
• 1261919-88-3(5-(3,5-Dimethylphenyl)-3-trifluoromethoxyphenol)
• 71274-84-5(1,1'-Biphenyl,4-(trifluoromethoxy)-)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)